Catalyst Wire Dossier Catalyst Wire Dossier

Herpes simplex glycoprotein D vaccine candidate (cell line A)

glycoprotein D vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Herpes simplex glycoprotein D vaccine candidate (cell line A), covering 2008-06-17 to 2008-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines [Phase 1, Phase 2]

See pricing